Diploid Genomics, Inc. (DGI), an AI-driven advanced genomics analytics company, launches in partnership with Healthier Capital, a leading health-tech venture capital firm, under the leadership of ...
Find out how AI influences drug discovery, enabling earlier predictions and reducing the risks in clinical development.
"CGIE (TM) is being built as future-facing infrastructure rather than a point solution," said Yusuf Henriques, Founder and CEO of IndyGeneUS Bio. "Our objective is to establish the AI×Bio Factory--the ...
India’s health care system is undergoing a major shift as genomics and artificial intelligence enable predictive, preventive, ...
Genomic medicine has revolutionized gynecological oncology, offering unprecedented insights into the molecular drivers of ...
Karthik Chava, a DevOps expert and AI researcher, has recently come up with a fully personalized healthcare ecosystem powered by big data, cloud infrastructure, and... The post Karthik Chava Proposes ...
In imaging, AI systems have demonstrated superior accuracy in breast cancer screening and skin lesion classification, often surpassing experienced clinicians. AI revolutionizes cancer care by ...
As clinical research evolves at an unprecedented pace, it’s important that physicians understand how emerging trends may ...
Oncology pharmacists bridge gaps in test ordering, result interpretation, and therapy access, ensuring timely and effective ...
The Centre of Genomics integrates national referral laboratories, NGS platforms and clinical expertise across specialties ...
Artificial intelligence (AI) is now woven into nearly every enterprise technology stack. Salesforce, SAP, Microsoft and others position AI as central to their platforms, while boards press executives ...